You are here
B-MoGen Biotechnologies Inc
UEI: N/A
# of Employees: 1
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
Amount: $1,406,084.00Cancer immunotherapy, particularly genetically engineered adoptive T cell transfer, has shown great potential for the treatment of cancer patients. The use of T cells engineered to express a specific ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
Amount: $218,588.00Abstract Cancer immunotherapyparticularly genetically engineered adoptive T cell transferhas shown great potential for the treatment of cancer patientsThe use of T cells engineered to express a specif ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Development of mitochondrial disease mouse models
Amount: $224,856.00Project Abstract Mitochondria are double membrane bound organelles that are found in all eukaryotic cells and carry a specialized circularkb genomeThere is a group of devastating human genetic disease ...
STTRPhase I2018Department of Health and Human Services National Institutes of Health -
Stable Gene Transfer by RNA Delivery
Amount: $224,634.00Abstract Non viral gene delivery is used in most biomedical laboratories for basic research and for many commercial and medical applications These include basic investigations into gene function mod ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Effective engineering of the mitochondrial genome
Amount: $224,564.00Abstract This proposal leverages our novel unprecedented and unique method for editing the mitochondrial genome B MoGen has exclusive license to this technology This proposal will finally provide ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Next Generation Genome Editing Tools
Amount: $149,431.44This proposal leverages our expertise in genetic engineering in general, our success in multiplex gene editing, and nanoparticle-based gene delivery to achieve targeted base editing of hepatitis B vir ...
SBIRPhase I2017Department of Defense Defense Advanced Research Projects Agency
